---
layout: post
title: "新冠药概念股走强，医药50ETF上涨0.42%"
date: 2022-02-14 14:39:07 +0800
categories: tiantianjijinwang
tags: 天天基金网新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.512120" data-code="512120|1|1" data-code2="512120|1|9|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.512120&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 512120_0" data-code="K 512120|1|1" data-code2="K 512120|1|9|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p> 博腾股份涨停，君实生物、凯莱英等涨幅居前，医药50ETF(512120)上涨0.42%。消息面上，国家药监局2月11日附条件批准辉瑞公司新冠病毒治疗药物。</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202142275677614>

[返回天天基金网新闻](//finews.withounder.com/category/tiantianjijinwang.html)｜[返回首页](//finews.withounder.com/)